Cargando…
COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury
In March 2020, the WHO declared coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a global pandemic. Obesity was soon identified as a risk factor for poor prognosis, with an increased risk of intensive care admissions and mechanical ventilat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415546/ https://www.ncbi.nlm.nih.gov/pubmed/34484128 http://dx.doi.org/10.3389/fendo.2021.726967 |
_version_ | 1783747986726060032 |
---|---|
author | Lasbleiz, Adèle Gaborit, Bénédicte Soghomonian, Astrid Bartoli, Axel Ancel, Patricia Jacquier, Alexis Dutour, Anne |
author_facet | Lasbleiz, Adèle Gaborit, Bénédicte Soghomonian, Astrid Bartoli, Axel Ancel, Patricia Jacquier, Alexis Dutour, Anne |
author_sort | Lasbleiz, Adèle |
collection | PubMed |
description | In March 2020, the WHO declared coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a global pandemic. Obesity was soon identified as a risk factor for poor prognosis, with an increased risk of intensive care admissions and mechanical ventilation, but also of adverse cardiovascular events. Obesity is associated with adipose tissue, chronic low-grade inflammation, and immune dysregulation with hypertrophy and hyperplasia of adipocytes and overexpression of pro-inflammatory cytokines. However, to implement appropriate therapeutic strategies, exact mechanisms must be clarified. The role of white visceral adipose tissue, increased in individuals with obesity, seems important, as a viral reservoir for SARS-CoV-2 via angiotensin-converting enzyme 2 (ACE2) receptors. After infection of host cells, the activation of pro-inflammatory cytokines creates a setting conducive to the “cytokine storm” and macrophage activation syndrome associated with progression to acute respiratory distress syndrome. In obesity, systemic viral spread, entry, and prolonged viral shedding in already inflamed adipose tissue may spur immune responses and subsequent amplification of a cytokine cascade, causing worse outcomes. More precisely, visceral adipose tissue, more than subcutaneous fat, could predict intensive care admission; and lower density of epicardial adipose tissue (EAT) could be associated with worse outcome. EAT, an ectopic adipose tissue that surrounds the myocardium, could fuel COVID-19-induced cardiac injury and myocarditis, and extensive pneumopathy, by strong expression of inflammatory mediators that could diffuse paracrinally through the vascular wall. The purpose of this review is to ascertain what mechanisms may be involved in unfavorable prognosis among COVID-19 patients with obesity, especially cardiovascular events, emphasizing the harmful role of excess ectopic adipose tissue, particularly EAT. |
format | Online Article Text |
id | pubmed-8415546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84155462021-09-04 COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury Lasbleiz, Adèle Gaborit, Bénédicte Soghomonian, Astrid Bartoli, Axel Ancel, Patricia Jacquier, Alexis Dutour, Anne Front Endocrinol (Lausanne) Endocrinology In March 2020, the WHO declared coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a global pandemic. Obesity was soon identified as a risk factor for poor prognosis, with an increased risk of intensive care admissions and mechanical ventilation, but also of adverse cardiovascular events. Obesity is associated with adipose tissue, chronic low-grade inflammation, and immune dysregulation with hypertrophy and hyperplasia of adipocytes and overexpression of pro-inflammatory cytokines. However, to implement appropriate therapeutic strategies, exact mechanisms must be clarified. The role of white visceral adipose tissue, increased in individuals with obesity, seems important, as a viral reservoir for SARS-CoV-2 via angiotensin-converting enzyme 2 (ACE2) receptors. After infection of host cells, the activation of pro-inflammatory cytokines creates a setting conducive to the “cytokine storm” and macrophage activation syndrome associated with progression to acute respiratory distress syndrome. In obesity, systemic viral spread, entry, and prolonged viral shedding in already inflamed adipose tissue may spur immune responses and subsequent amplification of a cytokine cascade, causing worse outcomes. More precisely, visceral adipose tissue, more than subcutaneous fat, could predict intensive care admission; and lower density of epicardial adipose tissue (EAT) could be associated with worse outcome. EAT, an ectopic adipose tissue that surrounds the myocardium, could fuel COVID-19-induced cardiac injury and myocarditis, and extensive pneumopathy, by strong expression of inflammatory mediators that could diffuse paracrinally through the vascular wall. The purpose of this review is to ascertain what mechanisms may be involved in unfavorable prognosis among COVID-19 patients with obesity, especially cardiovascular events, emphasizing the harmful role of excess ectopic adipose tissue, particularly EAT. Frontiers Media S.A. 2021-08-16 /pmc/articles/PMC8415546/ /pubmed/34484128 http://dx.doi.org/10.3389/fendo.2021.726967 Text en Copyright © 2021 Lasbleiz, Gaborit, Soghomonian, Bartoli, Ancel, Jacquier and Dutour https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Lasbleiz, Adèle Gaborit, Bénédicte Soghomonian, Astrid Bartoli, Axel Ancel, Patricia Jacquier, Alexis Dutour, Anne COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title | COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title_full | COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title_fullStr | COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title_full_unstemmed | COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title_short | COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury |
title_sort | covid-19 and obesity: role of ectopic visceral and epicardial adipose tissues in myocardial injury |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415546/ https://www.ncbi.nlm.nih.gov/pubmed/34484128 http://dx.doi.org/10.3389/fendo.2021.726967 |
work_keys_str_mv | AT lasbleizadele covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT gaboritbenedicte covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT soghomonianastrid covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT bartoliaxel covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT ancelpatricia covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT jacquieralexis covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury AT dutouranne covid19andobesityroleofectopicvisceralandepicardialadiposetissuesinmyocardialinjury |